4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-024317
Chief Scientific Officer sold 3,000 shares at an average $75.20 ($225,607)
- Chief Scientific Officer acquired 3,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Biller Scott Chief Scientific Officer | 2018-04-05 | Option exercise | +3,000 | $9.05 | $27,150 | 60,196 | D |
| Biller Scott Chief Scientific Officer | 2018-04-05 | Sale | −1,300 | $73.90 | $96,070 | 58,896 | D |
| Biller Scott Chief Scientific Officer | 2018-04-05 | Sale | −400 | $75.04 | $30,016 | 58,496 | D |
| Biller Scott Chief Scientific Officer | 2018-04-05 | Sale | −800 | $76.17 | $60,936 | 57,696 | D |
| Biller Scott Chief Scientific Officer | 2018-04-05 | Sale | −500 | $77.17 | $38,585 | 57,196 | D |
| Derivatives | |||||||
| Biller Scott Chief Scientific Officer | 2018-04-05 | Option exercise · Stock options (right to buy) | +3,000 | 25,154 | D | ||
| Open-market sales · 3,000 sh · avg $75.20 · $225,607 | |||||||
Loading xslF345X03/doc4.xml…